mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancerHarrison Cash(National Institutes of Health), Clint Allen(Johns Hopkins University)OncotargetOctober 22, 201510.18632/oncotarget.5063Cited by 53SaveCiteExport RISWatch citationsRelated PapersPhenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer|Cancer Cell|2023|70